Table 5.
Apical ischaemia (N = 145) | Other positive (N = 222) | P value | |
---|---|---|---|
Age | 62.7 ± 10.3 | 63.6 ± 11.7 | 0.339 |
Gender (male) | 63 (43.4%) | 144 (64.9%) | <0.001 |
Diabetes | 41 (28.3%) | 68 (30.6%) | 0.629 |
Smoking | 19 (13.1%) | 29 (13.1%) | 0.991 |
Hyperlipidaemia | 90 (62.1%) | 139 (62.6%) | 0.916 |
Hypertension | 95 (65.5%) | 164 (73.9%) | 0.086 |
CAD | 36 (24.8%) | 134 (60.4%) | <0.001 |
Positive FH | 29 (20.0%) | 51 (23.0%) | 0.500 |
Coronary angiogram | 58 (40.8%) | 153 (72.9%) | <0.001 |
Revascularisation | 12 (8.3%) | 64 (28.8%) | <0.001 |
Baseline EF | <0.001 | ||
Normal | 138 (95.2%) | 145 (65.3%) | |
Mildly impaired | 6 (4.1%) | 48 (21.6%) | |
Moderately/severely impaired | 1 (0.7%) | 29 (13.1%) | |
Cardiac deaths | 1 (0.7%) | 5 (2.3%) | 0.409 |
MACCE | 5 (3.5%) | 14 (6.5%) | 0.214 |
All-cause mortality | 2 (1.4%) | 15 (6.8%) | 0.017 |
CAD, coronary artery disease; EF, ejection fraction; FH, family history for early coronary artery disease; MACCE, major adverse cerebral and cardiovascular events. Bold values indicate statistical significance, P < 0.05.